Source: STAT News

Laronde: STAT+: Startup Laronde merges with another biotech in wake of data integrity issue

RNA medicines startup Laronde is merging with another startup in the wake of a scientific misconduct issue that affected its leading drug candidates.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
John Mendlein's photo - Interim-CEO of Laronde

Interim-CEO

John Mendlein

CEO Approval Rating

90/100

Read more